N/A
Completed N=121
Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy
Source: ClinicalTrials.gov NCT01525420 ↗Enrolled (actual)
121
Serious AEs
1.7%
Results posted
Apr 2014
Primary outcomePrimary: Number of Participants Who Stopped Smoking by 6 Month Post Treatment — 18; 14 participants
Summary
The purpose of this study is to demonstrate that Acceptance Therapy (ACT's) implementation outcomes are at least as good as those of traditional cognitive behavioral therapy (CBT).
Implementation outcomes:
* end of treatment and 6-month follow-up data retention rates;
* intervention implementation quality;
* number & length of calls completed.
Comparison of each arm's implementation
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Stopped Smoking by 6 Month Post Treatment |
18; 14 | — |
| SECONDARY 7-day and 24-hour Point Prevalence Quit Rates |
— | — |
Eligibility Criteria
Inclusion Criteria
- aged 18 and older;
- smokes at least 10 cigarettes daily and has done so for at least the past 12 months;
- wants to quit smoking in the next 30 days;
- willing to be randomly assigned to either group;
- willing and able to speak and read in English;
- willing and medically eligible to use nicotine replacement therapy (NRT),
- currently resides in the U.S., and expects to continue for at least 12 months;
- not participating in other smoking cessation interventions;
- has regular access to a telephone.
- has regular access to an email address.
Exclusion Criteria
- The Exclusion criteria are the opposite of the Inclusion criteria listed above. In addition, the following exclusion criteria also apply:
- another member of household enrolled in the study;
- currently using medication or nicotine replacement products to help with quitting smoking;
- currently using any non-cigarette tobacco products;
- pregnant or breastfeeding;
- had a heart attack in last 30 days;
- within the last 6 months, diagnosed with angina, heart pain, or irregular heartbeat;
- serious adverse reactions to nicotine patches including anaphylaxis and related symptoms such as hives, respiratory difficulty, and/or angioedema.
Data sourced from ClinicalTrials.gov (NCT01525420). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.